Top

Published in:

01-02-2011 | Review

Infection in total hip replacement: meta-analysis

Authors: Surendra Senthi, Jacob T. Munro, Rocco P. Pitto

Published in: International Orthopaedics | Issue 2/2011

Abstract

While total hip arthroplasty has progressed to become one of the most successful surgical procedures ever developed, infection remains a serious complication. We have conducted a review of the literature pertaining to management of deep infection in total hip arthroplasty, specifically focusing on clinically relevant articles published in the last five years. A search was conducted using MEDLINE and PubMed, as well as a review of the Cochrane database, using the terms “total hip arthroplasty”, “total hip replacement” and “infection”. References for all selected articles were cross-checked. While the so-called two-stage revision is generally considered to be the gold standard for management, numerous studies now report outcomes for implant retention and reassessing one-stage revision strategies. There are encouraging reports for complex reconstruction options in patients with associated severe bone stock loss. The duration of antibiotic therapy remains controversial. There is concern about increasing bacterial resistance especially with the widespread use of vancomycin and ertapenem (carbapenem).

Andollina A, Bertoni G, Zolezzi C, Trentani F, Trentani P, Maria Borrelli A, Tigani D (2008) Vancomycin and meropenem in acrylic cement: elution kinetics of in vitro bactericidal action. Chir Organi Mov 91(3):153–158, Epub May 21CrossRefPubMed

Anagnostakos K, Kelm J, Grün S, Schmitt E, Jung W, Swoboda S (2008) Antimicrobial properties and elution kinetics of linezolid-loaded hip spacers in vitro. J Biomed Mater Res B Appl Biomater 87(1):173–178PubMed

Baleani M, Persson C, Zolezzi C, Andollina A, Borelli AM, Tigani D (2008) Biological and biomechanical effects of vancomycin and meropenem in acrylic bone cement. J Arthroplasty 23:1232–1238CrossRefPubMed

Bertazzoni Minelli E, Benini A, Magnan B, Bartolozzi P (2004) Release of gentamicin and vancomycin from temporary human hip spacers in two-stage revision of infected arthroplasty. J Antimicrob Chemother 53(2):329–334CrossRefPubMed

Buttaro MA, Pusso R, Piccaluga F (2005) Vancomycin-supplemented impacted bone allografts in infected hip arthroplasty. Two-stage revision results. J Bone Joint Surg Br 87:314–319CrossRefPubMed

Byren I, Bejon P, Atkins BL, Angus B, Masters S, McLardy-Smith P, Gundle R, Berendt A (2009) One hundred and twelve infected arthroplasties treated with ‘DAIR’ (debridement, antibiotics and implant retention): antibiotic duration and outcome. J Antimicrob Chemother 63:1264–1271CrossRefPubMed

Cabrita H, Camargo O, Lucia Lima A, Croci A (2010) Prospective study of the treatment of infected hip arthroplasties with or without the use of an antibiotic loaded cement spacer. J Bone Joint Surg Br 92-B(Supp II):314

Colyer RA, Capello WN (1994) Surgical treatment of the infected hip implant. Two-stage reimplantation with a one-month interval. Clin Orthop Relat Res 298:75–79PubMed

Coventry MB (1975) Treatment of infections occurring in total hip surgery. Orthop Clin North Am 6:991–1003PubMed

10.

Disch AC, Matziolis G, Perka C (2007) Two-stage operative strategy without local antibiotic treatment for infected hip arthroplasty: clinical and radiological outcome. Arch Orthop Trauma Surg 127(8):691–697CrossRefPubMed

11.

Estes CS, Beauchamp CP, Clarke HD, Spangehl MJ (2010) A two-stage retention débridement protocol for acute periprosthetic joint infections. Clin Orthop Relat Res 468:2029–2038CrossRefPubMed

12.

Evans RP (2004) Successful treatment of total hip and knee infection with articulating antibiotic components: a modified treatment method. Clin Orthop Relat Res 427:37–46CrossRefPubMed

13.

Fink B, Grossmann A, Fuerst M, Schäfer P, Frommelt L (2009) Two-stage cementless revision of infected hip endoprostheses. Clin Orthop Relat Res 467:1848–1858CrossRefPubMed

14.

Fitzgerald RH (1995) Infected total hip arthroplasty: diagnosis and treatment. J Am Acad Orthop Surg 3:249–262PubMed

15.

Ganse B, Behrens P, Benthien JP (2008) Two-stage hip revision arthroplasty: the role of the excision arthroplasty. Eur J Orthop Surg Traumatol 18(3):223–228CrossRef

16.

Garvin KL, Hanssen AD (1995) Infection after total hip arthroplasty. Past, present, and future. J Bone Joint Surg Am 77:1576–1588PubMed

17.

Hofmann AA, Goldberg TD, Tanner AM, Cook TM (2005) Ten-year experience using an articulating antibiotic cement hip spacer for the treatment of chronically infected total hip. J Arthroplasty 20:874–879CrossRefPubMed

18.

Hsieh PH, Shih CH, Chang YH, Lee MS, Yang WE, Shih HN (2005) Treatment of deep infection of the hip associated with massive bone loss: two-stage revision with an antibiotic-loaded interim cement prosthesis followed by reconstruction with allograft. J Bone Joint Surg Br 87:770–775CrossRefPubMed

19.

Hsieh PH, Huang KC, Lee PC, Lee MS (2009) Two-stage revision of infected hip arthroplasty using an antibiotic-loaded spacer: retrospective comparison between short-term and prolonged antibiotic therapy. J Antimicrob Chemother 64(2):392–397CrossRefPubMed

20.

Hsieh PH, Shih CH, Chang YH, Lee MS, Shih HN, Yang WE (2004) Two-stage revision hip arthroplasty for infection: comparison between the interim use of antibiotic-loaded cement beads and a spacer prosthesis. J Bone Joint Surg Am 86:1989–1997PubMed

21.

Jackson WO, Schmalzried TP (2000) Limited role of direct exchange arthroplasty in the treatment of infected total hip replacements. Clin Orthop Relat Res 381:101–105CrossRefPubMed

22.

Jung J, Schmid NV, Kelm J, Schmitt E, Anagnostakos K (2009) Complications after spacer implantation in the treatment of hip joint infections. Int J Med Sci 6(5):265–273PubMed

23.

Koo KH, Yang JW, Cho SH, Song HR, Park HB, Ha YC, Chang JD, Kim SY, Kim YH (2001) Impregnation of vancomycin, gentamicin, and cefotaxime in a cement spacer for two-stage cementless reconstruction in infected total hip arthroplasty. J Arthroplasty 16:882–892CrossRefPubMed

24.

Kraay MJ, Goldberg VM, Fitzgerald SJ, Salata MJ (2005) Cementless two-staged total hip arthroplasty for deep periprosthetic infection. Clin Orthop Relat Res 441:243–249CrossRefPubMed

25.

Leunig M, Chosa E, Speck M, Ganz R (1998) A cement spacer for two-stage revision of infected implants of the hip joint. Int Orthop 22:209–214CrossRefPubMed

26.

Lieberman JR, Callaway GH, Salvati EA, Pellici PM, Brause BD (1994) Treatment of the infected total hip arthroplasty with a two-stage reimplantation protocol. Clin Orthop Relat Res 301:205–212PubMed

27.

Masri BA, Panagiotopoulos KP, Greidanus NV, Garbuz DS, Duncan CP (2007) Cementless two-stage exchange arthroplasty for infection after total hip arthroplasty. J Arthroplasty 22:72–78CrossRefPubMed

28.

McKenna PB, O’Shea K, Masterson EL (2009) Two-stage revision of infected hip arthroplasty using a shortened post-operative course of antibiotics. Arch Orthop Trauma Surg 129:489–494CrossRefPubMed

29.

Nestor BJ, Hanssen AD, Ferrer-Bonzalez R, Fitzgerald RH (1994) The use of porous prostheses in delayed reconstruction of total hip replacements that have failed because of infection. J Bone Joint Surg Am 76:349–359PubMed

30.

Penner MJ, Masri BA, Duncan CP (1996) Elution characteristics of vancomycin and tobramycin combined in acrylic bone-cement. J Arthroplasty 11:939–944CrossRefPubMed

31.

Romanò CL, Romanò D, Logoluso N, Meani E (2010) Long-stem versus short-stem preformed antibiotic-loaded cement spacers for two-stage revision of infected total hip arthroplasty. Hip Int 20(1):26–33PubMed

32.

Rudelli S, Uip D, Honda E, Lima ALLM (2008) One-stage revision of infected total hip arthroplasty with bone graft. J Arthroplasty 23:1165–1177CrossRefPubMed

33.

Scharfenberger A, Clark M, Lavoie G, O’Connor G, Masson E, Beaupre LA (2007) Treatment of an infected total hip replacement with the PROSTALAC system. Part 1: infection resolution. Can J Surg 50:24–28PubMed

34.

Schröder J, Saris D, Besselaar PP, Marti RK (1998) Comparison of the results of the Girdlestone pseudoarthrosis with reimplantation of a total hip replacement. Int Orthop 22:215–218CrossRefPubMed

35.

Seldes RM, Winiarsky R, Jordan LC, Baldini T, Brause B, Zodda F, Sculco TP (2005) Liquid gentamicin in bone cement: a laboratory study of a potentially more cost-effective cement spacer. J Bone Joint Surg Am 87(2):268–272CrossRefPubMed

36.

Soriano A, García S, Bori G, Almela M, Gallart X, Macule J, Sierra J, Martínez JA, Suso S, Mensa J (2006) Treatment of acute post-surgical infection of joint arthroplasty. Clin Microbiol Infect 12:930–933CrossRefPubMed

37.

Stockley I, Mockford BJ, Hoad-Reddick A, Norman P (2008) The use of two-stage exchange arthroplasty with depot antibiotics in the absence of long-term antibiotic therapy in infected total hip replacement. J Bone Joint Surg Br 90(2):145–148CrossRefPubMed

38.

Toms AD, Davidson D, Masri BA, Duncan CP (2006) The management of peri-prosthetic infection in total joint replacement. J Bone Joint Surg Br 88:149–155PubMed

39.

Trebse R, Pisot V, Trampuz A (2005) Treatment of infected retained implants. J Bone Joint Surg Br 87(2):249–256CrossRefPubMed

40.

Tsukayama DT, Estrada R, Gustilo RB (1996) Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections. J Bone Joint Surg Am 78:512–523PubMed

41.

Whittaker JP, Warren RE, Jones RS, Gregson PA (2009) Is prolonged systemic antibiotic treatment essential in two-stage revision hip replacement for chronic Gram-positive infection? J Bone Joint Surg Br 91:44–51PubMed

42.

Winkler H, Stoiber A, Kaudela K, Winter F, Menschik F (2008) One stage uncemented revision of infected total hip replacement using cancellous allograft bone impregnated with antibiotics. J Bone Joint Surg Br 90:1580–1585CrossRefPubMed

43.

Yamamoto K, Miyagawa N, Masaoka T, Katori Y, Shishido T, Imakiire A (2009) Cement spacer loaded with antibiotics for infected implants of the hip joint. J Arthroplasty 24:83–89CrossRefPubMed

44.

Yoo JJ, Kwon YS, Koo KH, Yoon KS, Kim YM, Kim HJ (2009) One-stage cementless revision arthroplasty for infected hip replacements. Int Orthop 33:1195–1201CrossRefPubMed

45.

Younger ASE, Duncan CP, Masri BA, McGraw RW (1997) The outcome of two-stage arthroplasty using a custom-made interval spacer to treat the infected hip. J Arthroplasty 12:615–623CrossRefPubMed

Title: Infection in total hip replacement: meta-analysis
Authors: Surendra Senthi
Jacob T. Munro
Rocco P. Pitto
Publication date: 01-02-2011
Publisher: Springer-Verlag
Published in: International Orthopaedics / Issue 2/2011
Print ISSN: 0341-2695
Electronic ISSN: 1432-5195
DOI: https://doi.org/10.1007/s00264-010-1144-z

At a glance: The STEP trials

Springer Medicine

Infection in total hip replacement: meta-analysis

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2011

Distal locking stem for revision femoral loosening and peri-prosthetic fractures

Results of hip resurfacing

Excellent results with cementless total hip arthroplasty and alumina-on-alumina pairing: minimum ten-year follow-up

Comments on Smith et al.: Minimally invasive versus conventional exposure for total hip arthroplasty: a systematic review and meta-analysis of clinical and radiological outcomes

Cementless acetabular revision: past, present, and future

Estimating implant survival in the presence of competing risks